KAT8 and renal cell carcinoma: A frequent downregulation of hMOF in primary breast carcinomas, renal cell carcinoma and medulloblastomas has been identified and the reduction in hMOF protein expression has been shown to correlate with H4K16 acetylation in those tumors (17,21).